Theravance Biopharma
TBPH
TBPH
119 hedge funds and large institutions have $546M invested in Theravance Biopharma in 2023 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 29 increasing their positions, 49 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
119
Holders Change
+6
Holders Change %
+5.31%
% of All Funds
1.88%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
16
Increased
29
Reduced
49
Closed
10
Calls
$431K
Puts
$299K
Net Calls
+$132K
Net Calls Change
-$1.36M
Top Buyers
| 1 |
PAMS
1
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
$19.1M |
| 2 |
2
Jane Street
New York
|
$4.41M |
| 3 |
HF
3
HRT Financial
New York
|
$3.12M |
| 4 |
JFG
4
Jefferies Financial Group
New York
|
$3.11M |
| 5 |
5
SG Americas Securities
New York
|
$1.56M |
